The global pandemic turned Moderna into a household name as one of the primary COVID-19 vaccine manufacturers. Now, according to a recent FiercePharma article, the company is investing $500 million in a manufacturing facility in Kenya. First announced in October of 2021, the site will focus on the production of up to 500 million vaccines a year. In the future, the site could expand to include fill-finish and packaging capabilities under the same roof. Though the exact location and size of the facility have yet to be disclosed, the company is planning to have the site built and operational by 2023.
Moderna to Open mRNA Manufacturing Facility in Kenya
The $500 million state-of-the-art site will produce up to 500 million vaccine doses a year.
Mar 11, 2022
List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
